title: NO inhalation reduces pulmonary arterial pressure but not hemorrhage in maximally exercising horses.
abstract: In horses, the exercise-induced elevation of pulmonary arterial pressure (Ppa) is thought to play a deterministic role in exercise-induced pulmonary hemorrhage (EIPH), and thus treatment designed to lower Ppa might reasonably be expected to reduce EIPH. Five Thoroughbred horses were run on a treadmill to volitional fatigue (incremental step test) under nitric oxide (NO; inhaled 80 ppm) and control (N(2), same flow rate as per NO run) conditions (2 wk between trials; order randomized) to test the hypothesis that NO inhalation would reduce maximal Ppa but that this reduction may not necessarily reduce EIPH. Before each investigation, a microtipped pressure transducer was placed in the pulmonary artery 8 cm past the pulmonic valve to monitor Ppa. EIPH severity was assessed via bronchoalveolar lavage (BAL) 30 min postrun. Exercise time did not differ between the two trials (P > 0.05). NO administration resulted in a small but consistent and significant reduction in peak Ppa (N(2), 102.3 +/- 4.4; NO, 98.6 +/- 4.3 mmHg, P < 0.05). In the face of lowered Ppa, EIPH severity was significantly higher in the NO trial (N(2), 22.4 +/- 6.8; NO, 42.6 +/- 15.4 x 10(6) red blood cells/ml BAL fluid, P < 0.05). These findings support the notion that extremely high Ppa may reflect, in part, an arteriolar vasoconstriction that serves to protect the capillary bed from the extraordinarily high Ppa evoked during maximal exercise in the Thoroughbred horse. Furthermore, these data suggest that exogenous NO treatment during exercise in horses may not only be poor prophylaxis but may actually exacerbate the severity of EIPH.
authors.affiliation: Department of Anatomy and Physiology, Kansas State University, Manhattan, KS 66506-5802, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Kindig
authors.forename: P
authors.initials: P
authors.lastname: McDonough
authors.forename: M R
authors.initials: MR
authors.lastname: Finley
authors.forename: B J
authors.initials: BJ
authors.lastname: Behnke
authors.forename: T E
authors.initials: TE
authors.lastname: Richardson
authors.forename: D J
authors.initials: DJ
authors.lastname: Marlin
authors.forename: H H
authors.initials: HH
authors.lastname: Erickson
authors.forename: D C
authors.initials: DC
authors.lastname: Poole
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D006470:Hemorrhage / Q000209:etiology* / Q000503:physiopathology; D006736:Horses / Q000502:physiology*; D008171:Lung Diseases / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D009043:Motor Activity / Q000502:physiology*; D009569:Nitric Oxide / Q000008:administration & dosage* / Q000494:pharmacology; D011651:Pulmonary Artery / Q000187:drug effects* / Q000503:physiopathology
chemical_list: D009569:Nitric Oxide